These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 29050969)

  • 1. A novel selective MAO-B inhibitor with neuroprotective and anti-Parkinsonian properties.
    Chan HH; Tse MK; Kumar S; Zhuo L
    Eur J Pharmacol; 2018 Jan; 818():254-262. PubMed ID: 29050969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline.
    Kupsch A; Sautter J; Götz ME; Breithaupt W; Schwarz J; Youdim MB; Riederer P; Gerlach M; Oertel WH
    J Neural Transm (Vienna); 2001; 108(8-9):985-1009. PubMed ID: 11716151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (-)-Deprenyl, a selective MAO-B inhibitor, with apoptotic and anti-apoptotic properties.
    Magyar K; Szende B
    Neurotoxicology; 2004 Jan; 25(1-2):233-42. PubMed ID: 14697898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indole-Substituted Benzothiazoles and Benzoxazoles as Selective and Reversible MAO-B Inhibitors for Treatment of Parkinson's Disease.
    Nam MH; Park M; Park H; Kim Y; Yoon S; Sawant VS; Choi JW; Park JH; Park KD; Min SJ; Lee CJ; Choo H
    ACS Chem Neurosci; 2017 Jul; 8(7):1519-1529. PubMed ID: 28332824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity.
    Muralikrishnan D; Samantaray S; Mohanakumar KP
    Synapse; 2003 Oct; 50(1):7-13. PubMed ID: 12872288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective and behavioural assessments of an imidazolium compound (DBZIM) in a rat model of Parkinson's disease induced by 6-OHDA.
    Chan HH; Kumar S; Zhuo L
    Eur J Pharmacol; 2013 Sep; 715(1-3):405-13. PubMed ID: 23652161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1-[2-(4-Benzyloxyphenoxy)Ethyl]Imidazole inhibits monoamine oxidase B and protects against neuronal loss and behavioral impairment in rodent models of Parkinson's disease.
    Chung JY; Lee JW; Ryu CH; Min HK; Yoon YJ; Lim MJ; Park CH
    J Neurosci Res; 2015 Aug; 93(8):1267-78. PubMed ID: 25711470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective aspects of a novel MAO-B inhibitor PF9601N.
    Pérez V; Morón J; Pastó M; Unzeta M
    Neurobiology (Bp); 2000; 8(3-4):231-6. PubMed ID: 11225513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of transcription factor SP1 produces neuroprotective effects through decreasing MAO B activity in MPTP/MPP
    Yao L; Dai X; Sun Y; Wang Y; Yang Q; Chen X; Liu Y; Zhang L; Xie W; Liu J
    J Neurosci Res; 2018 Oct; 96(10):1663-1676. PubMed ID: 30004136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-Deprenyl and MDL72974 do not improve the recovery of dopaminergic cells following systemic administration of MPTP in mouse.
    Thiffault C; Lamarre-Théroux L; Quirion R; Poirier J
    Brain Res Mol Brain Res; 1997 Mar; 44(2):238-44. PubMed ID: 9073165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoamine Oxidase-B Inhibition Facilitates α-Synuclein Secretion
    Nakamura Y; Arawaka S; Sato H; Sasaki A; Shigekiyo T; Takahata K; Tsunekawa H; Kato T
    J Neurosci; 2021 Sep; 41(35):7479-7491. PubMed ID: 34290084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substantial protection against MPTP-associated Parkinson's neurotoxicity in vitro and in vivo by anti-cancer agent SU4312 via activation of MEF2D and inhibition of MAO-B.
    Guo B; Hu S; Zheng C; Wang H; Luo F; Li H; Cui W; Yang X; Cui G; Mak S; Choi TC; Ma ED; Wang Y; Lee SMY; Zhang Z; Han Y
    Neuropharmacology; 2017 Nov; 126():12-24. PubMed ID: 28807675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of nitric oxide synthase against MPTP neurotoxicity in mice.
    Kurosaki R; Muramatsu Y; Michimata M; Matsubara M; Kato H; Imai Y; Itoyama Y; Araki T
    Neurol Res; 2002 Oct; 24(7):655-62. PubMed ID: 12392201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective effect of the monoamine oxidase inhibitor PF 9601N [N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine] on rat nigral neurons after 6-hydroxydopamine-striatal lesion.
    Cutillas B; Ambrosio S; Unzeta M
    Neurosci Lett; 2002 Aug; 329(2):165-8. PubMed ID: 12165403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotection of MPTP-induced toxicity in zebrafish dopaminergic neurons.
    McKinley ET; Baranowski TC; Blavo DO; Cato C; Doan TN; Rubinstein AL
    Brain Res Mol Brain Res; 2005 Nov; 141(2):128-37. PubMed ID: 16209898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective rather than neurorescue or neurorestorative effect of selegiline against MPTP-induced dopaminergic toxicity.
    Wu WR; Zhu XZ; Guan HJ; Wang RG; Ji XQ
    Zhongguo Yao Li Xue Bao; 1999 Feb; 20(2):146-50. PubMed ID: 10437162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of MAO-B inhibitors on MPP+ toxicity in Vivo.
    Wu RM; Chen RC; Chiueh CC
    Ann N Y Acad Sci; 2000; 899():255-61. PubMed ID: 10863544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [History of deprenyl--the first selective inhibitor of monoamine oxidase type B].
    Knoll J
    Vopr Med Khim; 1997; 43(6):482-93. PubMed ID: 9503565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease.
    Du Y; Ma Z; Lin S; Dodel RC; Gao F; Bales KR; Triarhou LC; Chernet E; Perry KW; Nelson DL; Luecke S; Phebus LA; Bymaster FP; Paul SM
    Proc Natl Acad Sci U S A; 2001 Dec; 98(25):14669-74. PubMed ID: 11724929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New horizons in molecular mechanisms underlying Parkinson's disease and in our understanding of the neuroprotective effects of selegiline.
    Gerlach M; Desser H; Youdim MB; Riederer P
    J Neural Transm Suppl; 1996; 48():7-21. PubMed ID: 8988458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.